Medigus Ltd. (MDGS) |
|
5.0324 -0.188 (-3.59%)
|
01-27 14:50 |
|
Open: |
5.0694 |
Pre. Close: |
5.22 |
|
High:
|
5.14 |
Low:
|
4.9 |
|
Volume:
|
9,201 |
Market Cap:
|
8(M) |
|
|
|
Technical analysis |
as of: 2023-01-27 4:46:12 PM |
|
Overall:
|
  |
| Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected. |
| Target: |
Six months: 6.05 One year: 6.58 |
| Support: |
Support1: 4.44 Support2: 3.69 |
| Resistance: |
Resistance1: 5.18 Resistance2: 5.63 |
| Pivot: |
4.99 |
| Moving Average: |
MA(5): 5.05 MA(20): 4.96
MA(100): 6.64 MA(250): 10.29 |
| MACD: |
MACD(12,26): -0.2  Signal(9): -0.3 |
| Stochastic oscillator: |
%K(14,3): 74 %D(3): 73.3 |
| RSI: |
RSI(14): 43.8 |
| 52-week: |
High: 19.5 Low: 0.6 |
| Average Vol(K): |
3-Month: 38 (K) 10-Days: 13 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ MDGS ] has closed above bottom band by 41.8%. Bollinger Bands are 76.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 12 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
5.15 - 5.18 |
5.18 - 5.2 |
|
Low:
|
4.83 - 4.87 |
4.87 - 4.89 |
|
Close:
|
4.91 - 4.96 |
4.96 - 5.01 |
|
Company Description |
|
Medigus Ltd., a technology-based company, provides medical-related devices and products in the United States, Europe, China, Israel, and internationally. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities. In addition, it develops, markets, and distributes software for internet users; and operates online stores for the sale of various consumer products on the Amazon online marketplace, as well as an online event management and ticketing platform. Further, the company develops, produces, and markets miniaturized imaging equipment, visualization solutions, and resistant cameras; electric vehicles; and wireless vehicle battery charging technologies. Medigus Ltd. was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel. |
Headline News |
Sat, 28 Jan 2023
Moundridge boys top Goessel – The Kansan - Newton Kansan
Fri, 27 Jan 2023
Poverty eradication with Chinese characteristics - EU Reporter
Thu, 26 Jan 2023
JBLE Medical Clinics stand up Walk-in Contraception Clinic - jble.af.mil
Thu, 26 Jan 2023
The Power Of The Pivot To Achieve Corporate Sustainability Goals - Forbes
Fri, 20 Jan 2023
5th Medical Group Utilizes Trinity Health's SIM Truck for Training Day - Minot Air Force Base
Thu, 12 Jan 2023
51st MDG trains on the TK2 - osan.af.mil
|
Financial Analysis |
| Price to Book Value: |
Neutral |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Neutral |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Neutral |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. |
0 (M) |
| Shares Float |
2 (M) |
|
% Held by Insiders
|
1.63e+006 (%) |
|
% Held by Institutions
|
0 (%) |
|
Shares Short
|
5 (K) |
|
Shares Short P.Month
|
0 (K) |
Stock Financials |
|
EPS
|
-4.91e+006 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
0 |
|
Profit Margin (%)
|
-15.5 |
|
Operating Margin (%)
|
-15.5 |
|
Return on Assets (ttm)
|
-5.3 |
|
Return on Equity (ttm)
|
-16.2 |
|
Qtrly Rev. Growth
|
1 |
|
Gross Profit (p.s.)
|
254.15 |
|
Sales Per Share
|
3.00563e+007 |
|
EBITDA (p.s.)
|
3.38028e+006 |
|
Qtrly Earnings Growth
|
0.2 |
|
Operating Cash Flow
|
0 (M) |
|
Levered Free Cash Flow
|
-5 (M) |
Stock Valuations |
|
PE Ratio
|
-0.01 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
0 |
|
Price to Sales
|
0 |
|
Price to Cash Flow
|
0.25 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
26960 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
2018-07-15 |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
